Hypertension and Metabolic Cardiovascular Risk Factors by Arrigo F. G. Cicero

By Arrigo F. G. Cicero

The objective of this consultant is to supply clinicians with sensible reference for the administration of hypertensive sufferers with different cardiovascular threat elements, which originate from impaired metabolic services. because of rigorously chosen, paradigmatic case experiences, the health practitioner will locate sound recommendation for the simplest method of universal yet usually under-recognized medical occasions, and solutions to sensible questions that come up whilst a selected situation isn't without delay addressed within the guidance. Question-and-answer sections may help the reader to spot at a look the main complicated steps within the diagnostic and healing technique.

In a “real international” scientific atmosphere, the hypertensive sufferer hardly ever provides with high blood pressure because the merely cardiovascular possibility issue, and is likely to be stricken by different metabolic threat elements, resembling impairment of lipid metabolism, glucose homeostasis, and purine metabolism, and through obese or weight problems. those circumstances will function a foundation for studying most sensible perform, highlighting difficulties in prognosis and remedy, and choosing the main applicable administration of sufferers with metabolic hazard components in daily practice.

Show description

Read or Download Hypertension and Metabolic Cardiovascular Risk Factors PDF

Similar endocrinology books

Basic Medical Endocrinology, Third Edition

Easy scientific Endocrinology, 3rd variation presents up to date insurance of speedily unfolding advances within the knowing of hormones all for regulating so much features of physically capabilities. The dialogue specializes in molecular and mobile points of hormone creation and motion firmly rooted within the context of integrative body structure.

The Local Cardiac Renin-Angiotensin Aldosterone System

Till lately, the renin-angiotensin-aldosterone process has been thought of a systemic endocrine hormonal approach solely. it's referred to now that every section of the renin-angiotensin process is produced, synthesized and certainly, found in many organisms together with the center and vessels. This quantity offers the newest scientific and laboratory stories of the prime physicians and investigators within the box of the neighborhood cardiac renin-angiotensin aldosterone method.

Dietary Magnesium: New Research

Magnesium is the fourth such a lot plentiful mineral within the physique and is vital to sturdy well-being. nearly 50 in line with cent of overall physique magnesium is located in bone. the opposite part is located predominantly inside of cells of physique tissues and organs. just one consistent with cent of magnesium is located in blood, however the physique works very challenging to maintain blood degrees of magnesium consistent.

Additional info for Hypertension and Metabolic Cardiovascular Risk Factors

Sample text

4. 28 Chapter 2. 4 Patient post-treatment 24-h ambulatory blood pressure chart Diagnostic Tests for Organ Damage or Associated Clinical Conditions The patient has moderate to severe carotid atheroma. However, currently her blood pressure and her diabetes are perfectly controlled. Current Treatment • Therapeutic lifestyle • Enalapril/lercanidipine 20/20 mg 1 tablet h. 00 • Metformin/sitagliptin 850/50 mg 1 tablet h. 00 and 1 tablet h. 00 • ASA 100 mg 1 tablet after lunch • Atorvastatin 20 mg 1 tablet h.

2014;46(2):97–102. 5. Nickenig G, Baumer AT, Temur Y, Kebben D, Jockenhovel F, Bohm M. Statin-sensitive dysregulated AT1 receptor function and density in hypercholesterolemic mend. Circulation. 1999;100:2131–4. 6. Sever P, Dahlöf B, Poulter N, Wedel H, Beevers G, Caulfield M, Collins R, Kjeldsen S, Kristinsson A, McInnes G, Mehlsen J, Nieminem M, O’Brien E. Ostergren J; ASCOT Steering Committee Members. Potential synergy between lipid-lowering and blood-pressure-lowering in the Anglo-Scandinavian Cardiac Outcomes Trial.

Sever P, Dahlöf B, Poulter N, Wedel H, Beevers G, Caulfield M, Collins R, Kjeldsen S, Kristinsson A, McInnes G, Mehlsen J, Nieminem M, O’Brien E. Ostergren J; ASCOT Steering Committee Members. Potential synergy between lipid-lowering and blood-pressure-lowering in the Anglo-Scandinavian Cardiac Outcomes Trial. Eur Heart J. 2006;27(24):2982–8. 1 Clinical Case Presentation Man, 59 years old, never a smoker, and mildly overweight from the young age, with nearly no physical activity (his working life is sedentary as the leisure one).

Download PDF sample

Rated 4.86 of 5 – based on 41 votes